AngioDynamics, Inc. announced the commencement of the AMBITION BTK multicenter randomized controlled trial (RCT), which will ev ...
Bentley InnoMed GmbH announced the launch of the BeGraft stent graft system, an on-label bridging device for fenestrated ...
Amplitude Vascular Systems (AVS), developer of the Pulse intravascular lithotripsy (PIVL) platform for the treatment of ...
Instylla, Inc., a developer of solutions for peripheral vascular embolotherapy, announced the FDA 510(k) clearance of the ...
Bentley InnoMed GmbH announced the market launch of its BeFlow iliac covered stent system, which will be commercially available ...
Imperative Care, Inc. announced that it has received FDA 510(k) clearance of the company’s Zoom system. The comprehensive ...
Cagent Vascular, Inc., a developer of serration technology for vessel dilation in endovascular interventions, announced the sta ...
Gore & Associates recently announced the first commercial use of the company’s Excluder conformable abdominal aortic ...
Front Line Medical Technologies announced the launch in the United Kingdom of its CE Mark–approved COBRA-OS—Control ...
Alan Lumsden, MD Walter W. Fondren III Presidential Distinguished Chair, DeBakey Heart & Vascular Center Chair, Department of ...
Aptyx, a Tempe, Arizona–based developer and manufacturer of complex components and devices for the life sciences, announc ...
Front Line Medical Technologies Inc. COBRA-OS REBOA (large vessel balloon occlusion device; 4-F; 25-mm diameter-balloon; guidewire-free) Distal Intended for temporary occlusion of large vessels ...